US equities
|
SPCX
$167.03
▲+5.08%
NVDA
$237.25
▲+1.41%
MU
$1,065.79
▼-0.85%
TSLA
$377.89
▲+1.97%
MSFT
$525.36
▲+1.51%
INTC
$116.53
▼-2.35%
SNDK
$1,713.94
▼-0.35%
META
$745.85
▲+2.44%
SPCX
$167.03
▲+5.08%
NVDA
$237.25
▲+1.41%
MU
$1,065.79
▼-0.85%
TSLA
$377.89
▲+1.97%
MSFT
$525.36
▲+1.51%
INTC
$116.53
▼-2.35%
SNDK
$1,713.94
▼-0.35%
META
$745.85
▲+2.44%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Hoth Therapeutics, Inc. - Common Stock
(NQ:
HOTH
)
1.360
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hoth Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
24 Stocks Moving in Wednesday's Pre-Market Session
↗
April 21, 2021
Gainers Welbilt, Inc. (NYSE: WBT) shares rose 15.4% to $18.03 in pre-market trading after The Middleby Corporation announced plans to acquire the company. Alterity Therapeutics...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
April 20, 2021
Gainers Artelo Biosciences (NASDAQ:ARTL) stock rose 5.26% to $1.2 during Tuesday's after-market session. This security traded at a volume of 43.6K shares come close, making up...
Via
Benzinga
Hoth Therapeutics' mRNA Frame Shifting Therapeutic Inhibits Tumor Growth, Animal Study Shows
↗
April 20, 2021
Hoth Therapeutics Inc (NASDAQ: HOTH) has reported that its novel anti-cancer therapeutic demonstrated positive results in humanized mast-cell neoplasm animal...
Via
Benzinga
Why Hoth Therapeutics's Stock is Up During Today's Session
↗
April 20, 2021
The Price And Volume Action In Hoth Therapeutics's Stock Today Hoth Therapeutics's (NASDAQ:
Via
Benzinga
The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex
↗
April 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Alexion Pharmaceuticals,...
Via
Benzinga
The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs
↗
April 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Ardelyx, Inc. (NASDAQ:...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
April 16, 2021
Before 10 a.m. ET Friday, 62 stocks made new 52-week lows. Significant Points: The largest company by market cap to set a new 52-week low was Yatsen Holding (NYSE:...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
